Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis

Innate immunity in alcoholic liver disease

(2011) Bin Gao et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets

(2011) Bin Gao et al.   GASTROENTEROLOGY

Kupffer cell activation and portal hypertension

(2011) C. J. Steib   GUT

Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS

(2011) P. Holland-Fischer et al.   GUT

Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells

(2010) Jessica I COHEN et al.   Journal of Digestive Diseases

Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163

(2010) Anders Etzerodt et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis

(2010) Christian J Steib et al.   LABORATORY INVESTIGATION

The clinical use of HVPG measurements in chronic liver disease

(2009) Jaime Bosch et al.   Nature Reviews Gastroenterology & Hepatology

Alcohol and Liver Fibrosis

(2009) Francisco Cubero et al.   SEMINARS IN LIVER DISEASE

Review article: the modern management of portal hypertension - primary and secondary prophylaxis of variceal bleeding in cirrhotic patients

(2008) J. C. GARCIA-PAGAN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS